Starting treatment for multiple sclerosis early — before symptoms even begin — could possibly delay the onset of the condition, new research finds. Preliminary results of a small Phase 3 clinical ...
In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in ...
Canada: A recent study published in the Multiple Sclerosis Journal has revealed that individuals who experienced psychiatric ...
Mothers with MS face longer diagnostic delays than women without children, especially those who are employed or single.
Research is ongoing regarding when multiple sclerosis develops and strategies for prompt diagnosis. A recent study found that people who went on to develop multiple sclerosis had a much higher use of ...
A new study has found that a drug called teriflunomide may delay the first symptoms of multiple sclerosis for people whose MRI scans show signs of MS. The researchers found that the drug can help even ...
Jan. 9, 2025 -- Multiple sclerosis (MS) is a complex condition that affects the brain and spinal cord. How does MS impact the body? What are the symptoms of MS? We spoke with Michael Levy, MD, PhD, to ...
A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...
Late-onset multiple sclerosis (MS) has poorer prognostic features but often lacks the inflammatory demyelination that is a target for treatment in younger patients. Investigators analysed data from ...
A recent Nutrients journal study determines whether diet influences the onset of multiple sclerosis (MS). Study: The Role of Diet in Multiple Sclerosis Onset: A Prospective Study Using UK Biobank.
Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...
While diagnostic criteria for typical multiple sclerosis (MS) perform well in people ages 18 to 50, differential diagnoses in pediatric-onset MS and late-onset MS require specific considerations.